Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 60.50 | -0.90% | -0.55 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | -0.90% | |
| 50 DMA Resistance | Bearish | -0.90% | |
| Death Cross | Bearish | -0.90% | |
| Shooting Star Candlestick | Bearish | -0.90% | |
| Crossed Above 20 DMA | Bullish | -0.90% | |
| 20 DMA Resistance | Bearish | 0.73% | |
| 200 DMA Resistance | Bearish | 0.73% | |
| 50 DMA Resistance | Bearish | 0.73% | |
| Multiple of Ten Bullish | Other | 0.73% | |
| Gapped Up | Strength | 0.73% |
| Alert | Time |
|---|---|
| Possible NR7 | about 2 hours ago |
| Possible Inside Day | about 2 hours ago |
| Gap Up Closed | about 4 hours ago |
| Gap Up Partially Closed | about 4 hours ago |
| 200 DMA Resistance | about 4 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 08/07/2024
ANI Pharmaceuticals, Inc. Description
ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Retail Outlets Pharmacology Suspension Manufacturing Facilities Contract Manufacturing Chloroarenes Contract Manufacturing Services Cough Estrogen Testosterone Antacid Antiemetics Laxatives Enema Metoclopramide Offers Contract Manufacturing Services Prolactin Releasers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 70.81 |
| 52 Week Low | 48.2 |
| Average Volume | 357,269 |
| 200-Day Moving Average | 61.23 |
| 50-Day Moving Average | 61.19 |
| 20-Day Moving Average | 60.33 |
| 10-Day Moving Average | 58.15 |
| Average True Range | 2.62 |
| RSI (14) | 52.61 |
| ADX | 15.47 |
| +DI | 24.93 |
| -DI | 23.35 |
| Chandelier Exit (Long, 3 ATRs) | 56.35 |
| Chandelier Exit (Short, 3 ATRs) | 60.39 |
| Upper Bollinger Bands | 65.96 |
| Lower Bollinger Band | 54.70 |
| Percent B (%b) | 0.56 |
| BandWidth | 18.66 |
| MACD Line | -0.84 |
| MACD Signal Line | -0.84 |
| MACD Histogram | -0.005 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 64.86 | ||||
| Resistance 3 (R3) | 65.05 | 63.97 | 64.23 | ||
| Resistance 2 (R2) | 63.97 | 63.00 | 63.88 | 64.01 | |
| Resistance 1 (R1) | 62.51 | 62.40 | 63.24 | 62.32 | 63.80 |
| Pivot Point | 61.43 | 61.43 | 61.80 | 61.34 | 61.43 |
| Support 1 (S1) | 59.97 | 60.46 | 60.70 | 59.78 | 58.30 |
| Support 2 (S2) | 58.89 | 59.86 | 58.80 | 58.09 | |
| Support 3 (S3) | 57.43 | 58.89 | 57.88 | ||
| Support 4 (S4) | 57.24 |
